- V-INCLUSION awarded by Novartis Pharmaceuticals Corporation 2024 - 2027
- Bayer AG - CKD Implementation -Multi-funded awarded by Bayer HealthCare Pharmaceuticals, Inc 2024 - 2026
- Gaziano, Thomas A., and Neha Pagidipati. Scaling up chronic disease prevention interventions in lower- and middle-income countries. Vol. 34, 2013. https://doi.org/10.1146/annurev-publhealth-031912-114402.
- Ashley, S. C., E. Kachhy, K. A. Brown, M. Prescott, M. D. Kelsey, R. W. McGarrah, N. J. Pagidipati, and N. P. Shah. “Clinical Update on the Intersection of Lipoprotein(a) and Calcific Valve Disease (Accepted).” Current Cardiovascular Risk Reports 19, no. 1 (December 1, 2025). https://doi.org/10.1007/s12170-025-00765-w.
- Osude, Nkiru, Harriette Van Spall, Hayden Bosworth, Konstantin Krychtiuk, John Spertus, Samuel Fatoba, Lee Fleisher, et al. “Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective.” Am Heart J 286 (August 2025): 18–34. https://doi.org/10.1016/j.ahj.2025.03.005.
- Rohatgi, A., S. S. Anand, M. Gadgil, U. P. Gujral, S. S. Jain, Z. Javed, M. Jha, et al. “South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population - An American society for preventive cardiology clinical practice statement (Accepted).” American Journal of Preventive Cardiology 22 (June 1, 2025). https://doi.org/10.1016/j.ajpc.2025.101000.
- Gaziano, T. A., and N. J. Pagidipati. “Global cardiovascular therapy.” In Cardiovascular Therapeutics: A Companion to Braunwald’s Heart Disease: Fourth Edition, 75–82, 2012. https://doi.org/10.1016/B978-1-4557-0101-8.00006-0.
- Kelsey, Michelle D., Hillary Mulder, Karen Chiswell, Zachary M. Lampron, Ester Nilles, Jacquelyn P. Kulinski, Parag H. Joshi, et al. “Contemporary patterns of lipoprotein(a) testing and associated clinical care and outcomes.” In Am J Prev Cardiol, 14:100478, 2023. https://doi.org/10.1016/j.ajpc.2023.100478.
Patient Reviews
Patient comments are gathered from our Press Ganey Patient Survey and displayed in their entirety.
Patients are de-identified for confidentiality and patient privacy